伊克力西斯 EXEL 深 沪
等待开盘 09-02 09:30:00 美东时间
56.89
+2.250
+4.12%
华盛通- 最 高56.97
- 今 开54.75
- 成交量 241.35万股
- 最 低 54.75
- 昨 收 54.64
- 总市值 140.96亿
- 52周最高 57.57
- 市盈率 静 20.49
- 换手率 0.97%
- 52周最低 33.755
- 委 比 70.00%
- 总股本 2.48亿
- 历史最高 57.57
- 量 比 1.33
- 振 幅 4.06%
- 历史最低 1.26
- 每 手 1
- 风险率 5.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Exelixis Announces Appellate Court Affirms Key Part Of 2024 Judgement Of U.S. District Court In Favor Of Co. Against MSN Laboratories; Appellate Court Upholds District Court Decision That Three Patents Are Not Invalid Covering Crystalline Malate Salt Of Cabozantinib
Exelixis, Inc. (NASDAQ:EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) vs. MSN Laboratories Private Limited et al. (MSN), Civil Action No. 22-00228 (Consolidated), the U.S. Court of Appeals for the Federal Circuit (Appeal No. 25-1236) has affirmed a key portion of the 2024 judgme...
09-01 02:48
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
BMO Capital Initiates Coverage On Exelixis with Market Perform Rating, Announces Price Target of $54
BMO Capital analyst David Lebowitz initiates coverage on Exelixis (NASDAQ:EXEL) with a Market Perform rating and announces Price Target of $54.
08-19 18:32
美股盘后 | Everpure, Inc. Class A大升7.83%，荷兰全球保险上升3.80%
Everpure, Inc. Class A大升7.83%；荷兰全球保险上升3.80%；Alcon上升3.48%
08-11 06:10
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
Stifel Maintains Hold on Exelixis, Raises Price Target to $51
Stifel analyst Stephen Willey maintains Exelixis (NASDAQ:EXEL) with a Hold and raises the price target from $47 to $51.
08-06 22:17
财报速睇 | 伊克力西斯 2026财年Q2营收6.29亿美元，同比增长10.7%；归母净利润2.12亿美元，同比增长14.6%
华盛资讯8月6日讯，伊克力西斯公布2026财年Q2业绩，公司Q2营收6.29亿美元，同比增长10.7%，归母净利润2.12亿美元，同比增长14.6%。
08-06 09:07
财报速睇 | 伊克力西斯 2026财年Q2营收6.29亿美元，同比增长10.7%；归母净利润2.12亿美元，同比增长14.6%
华盛资讯8月6日讯，伊克力西斯公布2026财年Q2业绩，公司Q2营收6.29亿美元，同比增长10.7%，归母净利润2.12亿美元，同比增长14.6%。
08-06 08:02
Exelixis Lowers FY2026 Sales Guidance from $2.525B-$2.625B to $2.500B-$2.550B vs $2.595B Est
Exelixis (NASDAQ:EXEL) lowers FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.500 billion-$2.550 billion vs $2.595 billion estimate.
08-06 04:23
Exelixis Q2 Adj. EPS $0.91 Beats $0.79 Estimate, Sales $628.700M Miss $635.951M Estimate
Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.79 by 15.19 percent. This is a 21.33 percent increase over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $628.700 million which ...
08-06 04:08
